Frederick W. Driscoll - 01 Jun 2021 Form 4 Insider Report for Flexion Therapeutics Inc

Role: Chief Financial Officer
Signature: /s/ Mark S. Levine, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 01 Jun 2021
Net transactions value: $0
Form type: 4
Filing time: 03 Jun 2021, 16:20:29 UTC
Next filing: 02 Jul 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FLXN	Common Stock	Award	$0	+28,000	+1045%	$0.000000	30,680	01 Jun 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FLXN	Stock option (right to buy)	Award	$0	+168,000		$0.000000	168,000	01 Jun 2021	Common Stock	168,000	$8.35	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a restricted stock unit award granted under the Issuer's 2013 Equity Incentive Plan.
F2	25% of the shares subject to the option shall vest on the one-year anniversary of May 17, 2021 (the "Vesting Commencement Date"), and 1/48th of the shares subject to the option shall vest each month following the one-year anniversary of the Vesting Commencement Date, so that all of the shares subject to the options shall be vested four years after the Vesting Commencement Date.